Hopkins H A, Sinkowitz-Cochran R L, Rudin B A, Keyserling H L, Jarvis W R
Hospital Infections Program, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia 30333, USA.
Infect Control Hosp Epidemiol. 2000 Jan;21(1):48-50. doi: 10.1086/501698.
Across-sectional study was performed of pediatric hematology-oncology patients who received vancomycin; use was compared to the Centers for Disease Control and Prevention (CDC) recommendations for vancomycin use. Thirty-seven patients received 308 doses of vancomycin. AR patients initially received vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations.
对接受万古霉素治疗的儿科血液肿瘤患者进行了一项横断面研究；将用药情况与疾病控制和预防中心（CDC）的万古霉素使用建议进行了比较。37名患者接受了308剂万古霉素。AR患者最初接受万古霉素作为经验性治疗；这种用药情况100%不符合CDC的建议。
